版本:
中国

BRIEF-Abeona Therapeutics' EB-101 clinical update to be presented at The Society for Investigative Dermatology annual meeting

April 25 Abeona Therapeutics Inc

* Abeona therapeutics announces EB-101 clinical update to be presented at The Society for Investigative Dermatology annual meeting

* Abeona Therapeutics - EB-101 well tolerated to date, demonstrated promising efficacy in phase 2 portion of ongoing phase 1/2 clinical trial in RDEB patients Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐